Flavio A. Cadegiani

Flavio A. Cadegiani Email and Phone Number

Flávio A. Cadegiani, MD, MSc, PhD.Founder, CEO, and medical director at Corpometria.Main researcher of the EROS Study. @ Unifesp - Universidade Federal de São Paulo
Flavio A. Cadegiani's Location
Federal District, Brazil, Brazil
About Flavio A. Cadegiani

Medical Doctor (MD), Board-Certified Endocrinologist and Internist. MSc and PhDs degrees obtained from the Federal University of São Paulo / Escola Paulista de Medicina (Unifesp/EPM).Creator and leader investigator of the Endocrine and Metabolic Responses on Overtraining Syndrome (EROS) study, one of the key studies on Overtraining Syndrome.Sole author of the book 'Overtraining Syndrome in Athletes - A Comprehensive Review and Novel Perspectives" (Springer Nature) (2nd edition in progress), a must-read book in the subject.Main PI of multiple clinical trials on COVID-19 and one of the key authors of the anti-androgen theory on COVID-19. Senior Editor of BMC Endocrine Disorders.Guest editor of multiple journals. Author of almost 50 peer-reviewed, PudMed indexed papers and studies.Approaching 2,000 citations in eight years. Nominated member of Sigma Xi.Chair at the Brazilian Academy of Sciences, Arts, History and Literature (ABRASCI), founded in 1910. World awarded “Contributions to Excellence in Research”.Founder, CEO and Medical Director of Instituto Corpometria.Shortly, a game-changer, health-driven Research Institute (already founded).

Flavio A. Cadegiani's Current Company Details
Unifesp - Universidade Federal de São Paulo

Unifesp - Universidade Federal De São Paulo

View
Flávio A. Cadegiani, MD, MSc, PhD.Founder, CEO, and medical director at Corpometria.Main researcher of the EROS Study.
Flavio A. Cadegiani Work Experience Details
  • Corpometria Institute
    Ceo Founder And Director
    Corpometria Institute May 2013 - Present
    Brasília, Distrito Federal, Brasil
  • Unifesp - Universidade Federal De São Paulo
    Orientador De Mestrado E Doutorado
    Unifesp - Universidade Federal De São Paulo Feb 2019 - Present
    São Paulo E Região, Brasil
    Orientador de alunos de mestrado e de doutorado pelo programa de Endocrinologia Clínica da Universidade Federal de São Paulo/Escola Paulista de Medicina (Unifesp/EPM)
  • Instituto Hospital De Base
    Médico Residente
    Instituto Hospital De Base Mar 2011 - Feb 2013
    Brasília E Região, Brasil
    Residência médica em Endocrinologia e Metabolismo.Fellowship (Residency equivalent) in Endocrinology & Metabolism.
  • Universidade De Brasília
    Médico Residente
    Universidade De Brasília Mar 2009 - Feb 2011
    Brasília E Região, Brasil
    Residência Médica em Clínica Médica (Medicina Interna).

Flavio A. Cadegiani Skills

Endocrinologia Medicina Interna Esportes Obesidade Endocrinologia Do Esporte

Flavio A. Cadegiani Education Details

Frequently Asked Questions about Flavio A. Cadegiani

What company does Flavio A. Cadegiani work for?

Flavio A. Cadegiani works for Unifesp - Universidade Federal De São Paulo

What is Flavio A. Cadegiani's role at the current company?

Flavio A. Cadegiani's current role is Flávio A. Cadegiani, MD, MSc, PhD.Founder, CEO, and medical director at Corpometria.Main researcher of the EROS Study..

What schools did Flavio A. Cadegiani attend?

Flavio A. Cadegiani attended Unifesp - Universidade Federal De São Paulo.

What skills is Flavio A. Cadegiani known for?

Flavio A. Cadegiani has skills like Endocrinologia, Medicina Interna, Esportes, Obesidade, Endocrinologia Do Esporte.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.